Sr Director, Market Access & Reimbursement

At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference. 
 
Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact. 
 
We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together. 
 
The Role: 

We have an exciting opportunity for a Senior Director, Market Access & Reimbursement to join the Gilead Japan affiliate in Tokyo.  

The Senior Director, Market Access & Reimbursement will be responsible for the development and implementation of the Japan Market Access Strategy, including NHI drug pricing, reimbursement, health technology assessment/cost-effectiveness evaluation, price revision and repricing strategies, and patient access for the Gilead product portfolio. This senior leader must work effectively across Gilead’s commercial, medical, regulatory, policy, public affairs, and global market access organizations, with a focus on both pipeline assets and the commercial portfolio. He/she will ensure that access strategies deliver robust pricing, reimbursement, and policy inputs aligned with Japan’s national health insurance environment, commercial ambitions, and patient access priorities. This individual will have demonstrated experience developing clear and compelling value propositions that reflect clinical, economic, societal, and unmet-need value within the Japanese healthcare system 

Reporting to the General Manager of Japan, this individual will be a key member of the Japan Leadership Team and will participate in broader strategic initiatives relating to the growth of the Japan affiliate. 

What you will do: 

•  Leads the development and implementation of Japan pricing strategy for new product launches and lifecycle management, including NHI price listing, premium opportunities, foreign price adjustment considerations, regular price revisions, and repricing risks such as market expansion repricing. 

• Leads the development and implementation of the local health economics, outcomes research, and cost-effectiveness evaluation strategy in alignment with global plans and Japan-specific evidence requirements. 

• Provides strategic leadership for NHI reimbursement submissions, value dossiers, and evidence packages to support optimal price listing and access outcomes in Japan. 

• Develops strategies to address Japan-specific price maintenance, repricing, cost-effectiveness evaluation, and post-listing price adjustment requirements across the product lifecycle. 

• Leads the development and implementation of tactics to support broad patient access under Japan’s universal health insurance system and appropriate positioning within clinical practice and treatment pathways. ​Develops and implements strategy to ensure patient access to current and future brands including inputs to global strategy development. 

•  In partnership with global policy organization, builds productive relationships with key national policy stakeholders, reimbursement decision makers, academic experts, patient organizations, and other influencers that affect NHI pricing, reimbursement, health technology assessment, and patient access in Japan. 

• In partnership with global public affairs organization, aligns stakeholder engagement plans that support optimal and timely patient access while reflecting Japan’s evolving healthcare policy and drug pricing environment

• Leads and develops the local Market Access team to ensure delivery of optimal performance and future growth and development of staff.  

• Responsible for the long-term growth and evolution of the department. 

• Member of Gilead Japan’s Senior Leadership team (JLT).  

• Builds productive relationships with key colleagues in other Gilead functions and affiliates (global, US and EU). 

Knowledge, Experience and Skills: 

• Strong strategic thinker with ability to formulate and develop complex strategy that results in action. 

• Strong portfolio management skills and ability to objectively frame analyze and resolve trade-offs between projects. 

• Able to effectively influence senior business leaders.  

• Excellent verbal, written and interpersonal skills in order to lead, interact with, focus, resolve conflict and drive consensus among individuals from a variety of disciplines. 

• Strong executive presence with ability to command respect through exercise of sound business judgment and clear decision-making. 

• Experience managing cross-functional teams or work groups as well as direct reports. 

• Successful experience developing productive external relationships across academia, the public sector and private sector. 

• Strong knowledge of Japanese pharmaceutical pricing and reimbursement issues, including NHI drug price listing, Chuikyo/MHLW decision-making processes, price revisions, premium rules, repricing mechanisms, cost-effectiveness evaluation, and policy trends affecting innovative medicines. 

• Demonstrated ability to anticipate policy and pricing implications for launch sequencing, evidence generation, lifecycle management, and cross-functional business planning in Japan. 

• Recognized expertise in implementing a pharmaceutical communication plan including advocacy development. 

• 14+ years of healthcare experience with broad experience in market access, pricing, HTA, key accounts and commercial operations required. 

• Advanced degree in economics, health economics, medicine, pharmacy, public health, health services research, business analytics, and/or financial analysis would be an asset. 

• Business level English and Japanese. 

Gilead Core Values: 

• Integrity (doing what's right)

• Teamwork (working together) 

• Excellence (being your best) 

• Accountability (taking personal responsibility)

• Inclusion (encouraging diversity) 

Gilead Leadership Commitment: 

• I AM BOLD in aspiration and AGILE in execution. 

• ​I CARE and make time for people. 

• ​I LISTEN, speak openly and explain the "why." 

• I TRUST others and myself to make sound decisions